Drug Evaluation Committee Presentation Slides: “Innovative Approaches by Pharmaceutical Manufacturers to Providing Drug Information and Future Prospects for Promoting Its Utilization” (October 18, 2026, 20th Annual Assembly of the Japanese Society of Pharmacy)

November 2026

This document is a lecture slide at the following symposium.

The 20th Annual Assembly of the Japanese Society of Pharmaceutical Sciences (October 18, 2026)

Symposium 10: “Are You Making the Most of It? The Latest Drug Safety Information—Moving from ‘Information You Know’ to ‘Information You Use’: Breaking Through Current Barriers”

Presentation Slides (Symposium 10, 20th Assembly of the Japanese Society of Community Pharmacy)

This presentation introduced the utilization of drug safety information in pharmacies, focusing on Risk Management Plans (RMPs) and RMP materials.

Based on the PMDA’s Reiwa 7 survey results, the presentation highlighted that challenges remain regarding the understanding and utilization of RMPs. Furthermore, it proposed a hypothesis identifying three barriers to utilization—“access,” “awareness,” and “application”—and introduced initiatives by pharmaceutical companies along with practical tips for implementing RMPs in pharmacies.Furthermore, the presentation offered a vision for creating an environment where stakeholders can collaborate so that the necessary information can be “encountered” at the right time and in the right context.

I hope the content of this presentation will serve as a helpful resource for considering the understanding and utilization of drug safety information.

Please note that the content of this presentation reflects the speaker’s personal views and is not intended to endorse any specific company, product, or service.

 Connecting Workflows and Information: Together with Government Agencies, System Vendors, and Pharmacies 1. Information Provision (PUSH) 1.1 PMDA: MediNavi, My Medication Collection | 1.2 Pharmaceutical Manufacturers: MRs, Email, Direct Mail | 1.3 Pharmacies: Pharmacy DI, Prescription Management Systems; Pharmacy Pharmacists 2. Proactive Search (PULL) 2.1 PMDA Website, My Medication Collection | 2.2 Pharmaceutical Companies: Websites, MRs, Call Centers | 2.3. Other Private-Sector Websites | 2.4. Generative AI | 2.5. Pharmacies: Pharmacy Drug Information (DI), Prescription Management Systems—Timely Integration of Systems and Information; Latest Drug Safety Information (Electronic Package Inserts, RMPs, RMP Materials, etc.) Future: Connecting Workflows and Information Through System Integration. The 20th Annual Assembly of the Japanese Society of Pharmacy, Symposium 10 | October 18, 2026
 Japan Pharmaceutical Manufacturers Association (JPMA) Co-creation: Moving from “Searching” for Information to “Encountering” It Within Workflows—Aiming for a System Where Connections Ensure the Right Information Reaches Users at the Right Time To Everyone: Starting Today—Begin with One Product; Use the “One-Page Summary” of the RMP to Verify Risks to Watch For and Key Messages to Communicate As Pharmaceutical Manufacturers:Moving forward, we will work with government agencies, system providers, and pharmacy professionals to develop mechanisms that integrate information into workflows. We aim to create an environment where reliable information is easily accessible—not only through web searches but also through AI-powered information discovery. To make materials more user-friendly, we also wish to collaborate with all stakeholders to establish a system for gathering feedback from users. Moving beyond simply delivering information to ensuring it is received and utilized.Information has value only when it is utilized in the right situations. We are committed to creating an environment where pharmaceutical safety information can be easily utilized when needed. The 20th Annual Assembly of the Japanese Society of Pharmacy, Symposium 10 | October 18, 2026

Share this page

TOP